Navigation Links
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Date:5/12/2008

o the market, Intercell is fully committed to becoming the leading pure play vaccine company globally. We look forward to welcoming Iomai's employees to Intercell and are excited by the potential of the combined group to create significant value for all stakeholders."

Stanley C. Erck, President and CEO of Iomai, said: "We have built a dynamic and scientifically driven organisation. This strategic combination with Intercell will create a stronger, more diversified vaccine company and will accelerate the development of Iomai's vaccine programs and fully leverage our innovative TCI technology. We believe this transaction is in the best interest of all parties, including shareholders, employees and ultimately patients."

Intercell will also gain full rights to two additional clinical and three preclinical programs under development, the most advanced being an immunostimulant vaccine patch in Phase II for pandemic influenza. This patch is designed to enhance the immune response compared to injected pandemic influenza vaccines. If successful, it would have the effect of expanding limited vaccine supplies by allowing public health officials to use fewer or lower doses of the vaccine. The vaccine patch has recently generated positive interim immunogenicity data in a 500-subject Phase I/II study with a one-dose application. The program is funded by a grant from the United States Department of Health and Human Services.

Iomai's pioneering work in transcutaneous immunization (TCI) technology has led to the development of a simple and promising needle-free vaccine patch. This highly innovative vaccine delivery system provides a potential future alternative to current injected vaccines. TCI technology has the potential to enhance the efficacy of existing vaccines, replace current vaccines that have a cumbersome mode of administration and enable the development of new vaccines that are not viable to be delivered via an injection.

Iomai's TCI technology
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
3. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...USNewswire/--America,spharmaceuticalresearchandbio...stotreatorpreventHIV/AIDSandrelatedconditions,acco...esearchandManufacturersofAmerica(PhRMA).December1m...enesscampaignthatoriginatedatthe1988WorldSummitofM..., "Wearegreatlyencouragedbythesecriticallyimporta...
(Date:11/24/2009)...PRNewswire-FirstCall/--IPCTheHospitalistCompany,In...ciangrouppracticecompany,announcedtodaythatPhilipV...spitalist asoneofthe2009TopTenHospitalistsinthenat...zine. ,, Dr.Vaidyanhasbeenapracticingphysicianf...pitalmedicineatSt.Mary,sHealthCenterinSt.Louis,Mis...
(Date:11/24/2009).../PRNewswire/--VisageImaging®,Inc.,awhollyowne...cingVisage®7,thecompany,snewgenerationdiagnos...iologicSocietyofNorthAmerica(RSNA),November29toDec...rsnewlevelsofversatilityandperformancetoradiologis...cians.TheVisage7UniversalViewerisasinglethinclient...
Breaking Medicine Technology:New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 1Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 2Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 3Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 1Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 1Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 3
(Date:11/24/2009)...ov.24/PRNewswire/--Mostpeoplelookforwardtokickingo...getherwithfriendsandfamily.TheMacombCountyHealthDe...gtheholidays.Travelingandbeinginlargegroupsareeasy...ayhealthy: ,, VACCINATION ,, Thefirstandmo...togetvaccinatedagainsttheH1N1strainoftheflu.TheMac...
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarew...pingHispanic-AmericanseniorsunderstandthebasicsofM...takeafreeZumba®Goldclass,aLatin-infusedfitnes...a,rumba,andtango. ,, UnitedHealthcarewilloffert...andengagedwhenlearningabouttheirhealthcareoptions....
(Date:11/24/2009)...Newswire-FirstCall/--CenteneCorporation(NYSE: CNC ...dhasselectedCenteneasoneoftwoCoordinatedCareOrgani...essNetwork(MississippiCAN),acoordinatedcareprogram...ngwiththeDivisiontoexecuteacontractinwhichthecompa...noliaHealthPlan(Magnolia). ,, BasedinJackson,Mi...
(Date:11/24/2009)...the falls that plague older adults, study finds, ... Falls are a leading cause of death among older Am...in contributes to those accidents. , "Pain cont... and is associated with mobility limitations that .... , "Chronic pain, no matter how we measured it...
(Date:11/24/2009)...ewswire-USNewswire/--TheAmericanDentalAssociation(...nnewdentalteammembersaspartofapilotprogramtoimprov...ommunityDentalHealthCoordinator(CDHC)isamemberofth...tshavelimitedaccesstodentalcaretoimprovetheiroralh...ivedentalcareservices--includingscreeningsandfluor...
Breaking Medicine News(10 mins):Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
...iscovery including solutions to tackle obesity, t...r and issues surrounding drugs used in sport and t...n Brighton next week. , The British Pharmacologic...ss the world. , Running from 16 to 18 December, t...
...Board of Medical Specialties (ABMS), the organizat...ialists in the United States, has appointed Richar...professional and scientific affairs. Hawkins will ...promote the science of ABMS Maintenance of Certifi...
...harmaceutical Companies, Inc. (NYSE: PRX ) today..., executive vice president and chief financial off...fessional opportunities. , , Lawrence A. Ke... Mr. Kenyon joins from Alfacell Corporation where ...
...ber 8, 2008, TooBusyWorking was launched as a next...s local nursing job openings from all major employ...has more local nursing job listings than CareerBui...s with information detailing commuting distance, s...
... malaria elimination can be achieved. A supplement...of articles reviewing the many aspects of the rese... of the supplement,s reviews charts the progress t...ferent vaccine strategy, since success will depend...
...rporation and Terumo,s,subsidiary, Terumo Cardiova...hey have entered into an agreement to settle all o...LLC. The companies have a number of lawsuits pend...All pending,disputes between the companies will be...
Other Medicine News:Health News:Leading pharmacologists to meet in Brighton 2Health News: ABMS Appoints Richard Hawkins, MD, FACP as New Senior Vice President for Professional and Scientific Affairs 2Health News: ABMS Appoints Richard Hawkins, MD, FACP as New Senior Vice President for Professional and Scientific Affairs 3Health News:Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer 2Health News:Malaria Journal supplement evaluates steps toward elimination 2
Standard Light Source 650.2
...nsists of two plastic parts that clamp a corneal g... cornea like a standard graft. The Boston Keratopr...s and has gradually been perfected. It received FD...been performed. It is the most commonly used kerat...
STAT E&M Coder
STAT ICD-9 Coder
Medicine Products: